Entries of Jordán-Garrote, Ana-Laura on the publication server
![]() | Up a level |
Number of items: 2.
2016
Chopra, Martin, Biehl, Marlene, Steinfatt, Tim, Brandl, Andreas, Kums, Juliane, Amich, Jorge
, Vaeth, Martin
, Kuen, Janina, Holtappels, Rafaela, Podlech, Jürgen, Mottok, Anja, Kraus, Sabrina, Jordán-Garrote, Ana-Laura, Bäuerlein, Carina A., Brede, Christian, Ribechini, Eliana, Fick, Andrea, Seher, Axel, Polz, Johannes, Ottmüller, Katja J., Baker, Jeanette, Nishikii, Hidekazu, Ritz, Miriam, Mattenheimer, Katharina, Schwinn, Stefanie, Winter, Thorsten, Schäfer, Viktoria, Krappmann, Sven
, Einsele, Hermann, Müller, Thomas D., Reddehase, Matthias J., Lutz, Manfred B., Männel, Daniela N., Berberich-Siebelt, Friederike, Wajant, Harald
and Beilhack, Andreas
(2016)
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.
The Journal of Experimental Medicine 213 (9), pp. 1881-1900.
Fulltext not available.
, Vaeth, Martin
, Kuen, Janina, Holtappels, Rafaela, Podlech, Jürgen, Mottok, Anja, Kraus, Sabrina, Jordán-Garrote, Ana-Laura, Bäuerlein, Carina A., Brede, Christian, Ribechini, Eliana, Fick, Andrea, Seher, Axel, Polz, Johannes, Ottmüller, Katja J., Baker, Jeanette, Nishikii, Hidekazu, Ritz, Miriam, Mattenheimer, Katharina, Schwinn, Stefanie, Winter, Thorsten, Schäfer, Viktoria, Krappmann, Sven
, Einsele, Hermann, Müller, Thomas D., Reddehase, Matthias J., Lutz, Manfred B., Männel, Daniela N., Berberich-Siebelt, Friederike, Wajant, Harald
and Beilhack, Andreas
(2016)
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.
The Journal of Experimental Medicine 213 (9), pp. 1881-1900.
Fulltext not available.
2015
Distler, Eva, Albrecht, Jana, Brunk, Ariane, Khan, Shamsul, Schnürer, Elke, Frey, Michaela, Mottok, Anja, Jordán-Garrote, Ana-Laura, Brede, Christian, Beilhack, Andreas, Mades, Andreas, Tomsitz, Dirk, Theobald, Matthias, Herr, Wolfgang and Hartwig, Udo F.
(2015)
Patient-individualized CD8+ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
International Journal of Cancer 138 (5), pp. 1256-1268.
Fulltext not available.
(2015)
Patient-individualized CD8+ cytolytic T-cell therapy effectively combats minimal residual leukemia in immunodeficient mice.
International Journal of Cancer 138 (5), pp. 1256-1268.
Fulltext not available.
